Intra-Cellular Therapies to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast
February 17 2021 - 08:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that it will host a conference call and live webcast
discussion at 8:30 a.m. Eastern Time on Thursday, February 25,
2021, to provide a corporate update and discuss details of the
Company's financial results for the quarter and year ended December
31, 2020.
To access the live conference call via phone, dial 1-(844)
835-6563. The international dial-in number is 1-(970) 315-3916. The
conference ID number for the live call is 8499868.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please log in
approximately 5-10 minutes prior to the event to register and to
download and install any necessary software.
About Intra-Cellular TherapiesIntra-Cellular
Therapies is a biopharmaceutical company founded on Nobel
prize-winning research that allows us to understand how therapies
affect the inner-workings of cells in the body. The company
leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases. For more information, please visit
www.intracellulartherapies.com.
Contact
Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President,
Corporate Communications and Investor Relations646-440-9333
Burns McClellan, Inc.Lisa
Burnsjgrimaldi@burnsmc.com212-213-0006
Source: Intra-Cellular Therapies Inc.
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2023 to Mar 2024